S'abonner

Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis - 05/03/22

Doi : 10.1016/j.tube.2022.102169 
Ruschca Jacobs a, Dolapo O. Awoniyi a, Ralf Baumann b, c, d, Kim Stanley a, Shirley McAnda a, Susanne Kaempfer b, Stephanus T. Malherbe a, Mahavir Singh b, Gerhard Walzl a, Novel N. Chegou a,

the AE-TBC Consortium1

  The AE-TBC Consortium.
Gerhard Walzl e, Novel N. Chegou e, Magdalena Kriel e, Gian van der Spuy e, Andre G. Loxton e, Kim Stanley e, Stephanus T. Malherbe e, Belinda Kriel e, Jayne S. Sutherland f, Olumuyiwa Owolabi f, Abdou Sillah f, Joseph Mendy f, Awa Gindeh f, Simon Donkor f, Toyin Togun f, Martin Ota f, Amelia C. Crampin g, Felanji Simukonda g, Alemayehu Amberbir g, Femia Chilongo g, Rein Houben g, Desta Kassa h, Atsbeha Gebrezgeabher h, Getnet Mesfin h, Yohannes Belay h, Gebremedhin Gebremichael h, Yodit Alemayehu h, Marieta van der Vyver i, Faustina N. Amutenya i, Josefina N. Nelongo i, Lidia Monye i, Jacob A. Sheehama i, Scholastica Iipinge i, Harriet Mayanja-Kizza j, Anna Ritah Namuganga j, Grace Muzanye j, Mary Nsereko j, Pierre Peters j, Rawleigh Howe k, Adane Mihret k, Yonas Bekele k, Bamlak Tessema k, Lawrence Yamuah k, Tom H.M. Ottenhoff l, Annemieke Geluk l, Kees Franken l, Jolien J. van der Ploeg-van Schip l, Paul L.A.M. Corstjens m, Elisa M. Tjon Kon Fat m, Claudia J. de Dood m, Ida Rosenkrands n, Claus Aagaard n, Stefan H.E. Kaufmann o, Maria M. Esterhuyse o, Jacqueline M. Cliff p, Hazel M. Dockrell p
e Stellenbosch University, South Africa 
f MRC Unit, The Gambia at LSHTM, South Africa 
g Karonga Prevention Study, Malawi 
h Ethiopian Health and Nutrition Research Institute (now known as the Ethiopian Public Health Institute), Ethiopia 
i University of Namibia, Namibia 
j Makerere University, Uganda 
k Armauer Hansen Research Institute, Ethiopia 
l Department of Infectious Diseases, Leiden University Medical Centre, the Netherlands 
m Department of Molecular Cell Biology, Leiden University Medical Centre, the Netherlands 
n Statens Serum Institute, Copenhagen, Denmark 
o Max Planck Institute for Infection Biology, Berlin, Germany 
p London School of Hygiene and Tropical Medicine, London, UK 

a DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa 
b Lionex Diagnostics and Therapeutics, Braunschweig, Germany 
c Medical Faculty, Institute for Translational Medicine, Medical School Hamburg (MSH) – Medical University, Hamburg, Germany 
d Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany 

Corresponding author. Biomedical Research Institute, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, P.O. Box 241, Cape Town, 8000, South Africa.Biomedical Research InstituteDivision of Molecular Biology and Human GeneticsFaculty of Medicine and Health SciencesStellenbosch UniversityP.O. Box 241Cape Town8000South Africa

Abstract

Background

Antibodies against mycobacterial proteins are highly specific, but lack sensitivity, whereas cytokines have been shown to be sensitive but not very specific in the diagnosis of tuberculosis (TB). We assessed combinations between antibodies and cytokines for diagnosing TB.

Methods

Immuoglubulin (Ig) A and IgM antibody titres against selected mycobacterial antigens including Apa, NarL, Rv3019c, PstS1, LAM, “Kit 1” (MTP64 and Tpx)”, and “Kit 2” (MPT64, Tpx and 19 kDa) were evaluated by ELISA in plasma samples obtained from individuals under clinical suspicion for TB. Combinations between the antibody titres and previously published cytokine responses in the same participants were assessed for diagnosing active TB.

Results

Antibody responses were more promising when used in combination (AUC of 0.80), when all seven antibodies were combined. When anti-“Kit 1”-IgA levels were combined with five host cytokine biomarkers, the AUC increased to 97% (92–100%) with a sensitivity of 95% (95% CI, 73–100%), and specificity of 88.5% (95% CI, 68.7–97%) achieved after leave-one-out cross validation.

Conclusion

When used in combination, IgA titres measured with ELISA against multiple Mycobacterium tuberculosis antigens may be useful in the diagnosis of TB. However, diagnostic accuracy may be improved if the antibodies are used in combination with cytokines.

Le texte complet de cet article est disponible en PDF.

Highlights

Antibody-based TB tests are known to be highly specific whereas host cytokine responses have been shown to be sensitive.
An approach involving the combination of anti-MTB antibodies and cytokines was assessed as a tool for TB diagnosis.
Antibodies alone were promising but diagnostic accuracy increased when they were used in combination with cytokines.
Combining antibodies with up to five host inflammatory biomarkers may be a useful approach for the diagnosis of TB.

Le texte complet de cet article est disponible en PDF.

Keywords : Tuberculosis, Antigens, Antibodies, Cytokines, Biomarkers, Diagnosis


Plan


© 2022  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 133

Article 102169- mars 2022 Retour au numéro
Article précédent Article précédent
  • Effective combined antiretroviral therapy provides partial immune recovery to mycobacterial antigens in vertically infected, BCG-vaccinated youth living with HIV
  • Mariana Virginello Castelhano, Paulo César Martins Alves, Vítor Schandler Macedo, Mauro Pedromonico Arrym, Fernando Guimarães, Patricia Costa Panunto, Taís Nitsch Mazzola, Renan Marrichi Mauch, Maria Marluce dos Santos Vilela, Marcos Tadeu Nolasco da Silva
| Article suivant Article suivant
  • Concentrated specimen smear microscopy utilising a polymer membrane sandwich filtration vessel for the detection of acid-fast bacilli in health facilities in Sabah, East Malaysia
  • Dawn Carmel Paul, Yun Fong Ngeow, Sook Fan Yap, Jiloris F. Dony, Richard Avoi, Rashidah Mohammad, Hien Fuh Ng

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.